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Confocal microscopyn blood and mucosal-derived HIV-1 strains have been widely reported. As
ampliﬁcation of HIV-1 strains from mucosal samples including semen or saliva by co-culture has low
sensitivity, we developed the construction of chimeric viruses expressing wild-type seminal HIV-1 envelope
protein. Chimeric viruses were produced by co-transfection of a V1–V3 deleted pNL 43 vector and PCR
fragments spanning the deleted region, ampliﬁed from HIV-1 RNA positive seminal plasma samples. After an
initial testing of co-receptor usage by a tropism recombinant test, replication capacity and ampliﬁcation of
these recombinant viruses were assessed using PBMC. Four chimeric replicative strains, all using CXCR4 as
coreceptor, were produced. The interaction between cell-free viral particles and reporter cell lines was
assessed by confocal microscopy. These replicative chimeras exhibiting HIV-1 env from seminal strains
represent useful tools for the in vitro study of the heterosexual transmission of HIV-1 and testing of
microbicide activity.
© 2009 Elsevier Inc. All rights reserved.Introduction
It is now well established that the entry of the human
immunodeﬁciency virus type 1 (HIV-1) into permissive cells relies
on an interaction between viral and cellular surface proteins. The
binding of the viral envelope glycoprotein gp120 to the cellular CD4
protein induces conformational changes in the former that reveal a
binding site for a cellular co-receptor (Sattentau and Moore, 1991; Wu
et al., 1996), principally via CXCR4 or CCR5 molecules (Philpott, 2003;
Simmons et al., 2000). It has been documented that a region spanning
the variable regions 1 to 3 of the gp120 (V1–V3) is largely responsible
for the interaction between the viral particle and its target cellular
receptors and that the amino acid composition of this region, most
notably of the V3 loop, can orientate the speciﬁc ability of a virus to
use one or the other co-receptor (Koning et al., 2002).
The predominant mode of global HIV transmission is through the
exposure of mucosal surfaces to male genital secretions carrying the
virus. Mucosa represents not only the primary route of entry for the
virus but also the initial and predominant site of viral replication and
ampliﬁcation. Evidence has shown that the local mucosal environ-
ment may inﬂuence viral replication, shedding and/or ultimatelyB. Pozzetto).
ll rights reserved.transmission (Brenchley et al., 2004; Veazey et al., 1998). In each
chronically infected individual, HIV exists as quasispecies of related
genetic variants and anatomic compartmentalization of these variants
has been described for blood, the central nervous system, the genital
tract, rectal mucosa, lung and saliva (Di Stefano et al., 2001; Gunthard
et al., 2001; Gupta et al., 2000; Kemal et al., 2003; Kiessling, 1992;
Liuzzi et al., 1996; Paranjpe et al., 2002; Singh et al., 1999; Zhang et al.,
2002).
Genetic differences between blood and semen-derived HIV-1 have
been widely reported (Byrn and Kiessling, 1998; Delwart et al., 1998;
Gupta et al., 2000; Vernazza et al., 1997; Zhu et al., 1996), due at least
in part to the fact that male genital tract tissues can serve as distinct
sites of replication leading to strains exhibiting speciﬁc characteristics
(Kiessling et al., 1998; Paranjpe et al., 2002; Ping et al., 2000). Recent
studies suggest that the male genital tract represents a selective
reservoir that leads to genetic bottlenecks associated with sexual
transmission of HIV-1 (Pillai et al., 2005). HIV isolates of mucosal
origin, either free virus or cell-associated, are seldom used in in vitro
studies of sexual transmission even though they are probably more
representative and pertinent than adapted laboratory strains. This is
partly because of the fact that the ampliﬁcation of HIV-1 strains from
semen samples by PBMC culture is fastidious and has low sensitivity
due to low virus loads and semen toxicity towards target cells
(Coombs et al., 1998; Vernazza et al., 1997).
Table 1
Clinical data of the 11 patients included in the study and comparison of V3 sequences from the seminal recombinant strains
Strain Clinical data Amino acids of the V3 loope Deduced
tropism
Numbera Sub-type Clinical stageb Viral loadc HAARTd Genof Phenog
LAI B – – – C T R P – N N N T R K S I R I Q R G P G R A F V T I G K I – G N M R Q A H C
BAL B – – – H – – L Y T I D I E R5 R5
594 B C3 4,5 Yes I I G H – – Y T Q V D I R5 X4
609 B A2 4,1 Yes H – – Y – D I D I Y R5 R5
611 CRF02_AG A2 6.0 No I G H – – Y T Q V D I R5 R5
611,6 T H I G H – – Y T Q V D I R5 R5
611,7 I G H – – Y A Q V D I R5 R5
611,9 I I G H – – Y T Q V D I R5 R5
654 B A3 6.0 Yes S I K R H H – – Y A T E R N – I X4 R5
654,12 G H – – Y T Q V D I R5 R5
662 B A3 3.5 Yes H – – Q T Y A T D I D I R5 R5
705 B B2 3.8 Yes S G P – – H – R I D I X4 X4
728 B B1 4.3 Yes R G H M – – M Y A T R I D I Y X4 X4
802 B C3 3.1 Yes P – – Y T D I D I R5 R5
803 CRF02_AG C3 6.0 No R K P – – D I X4 X4
804 B B3 3.6 Yes S R K L V R H H – – Y T R E T K I X4 X4
805 CRF02_AG C3 5.3 No V – – Q Y A T D I I R5 R5
a Patients' chimeric strains are designated by numbers. For strains 611 and 654, different clones were analyzed (see text).
b Clinical stage determined according to CDC classiﬁcation system for HIV infection.
c Viral load in blood expressed in log10 copies/ml.
d Highly active antiretroviral treatment.
e Alignment obtained with HIV-1 strain NL4-3 using CINEMA 5 software. Blanks indicate a match with the reference sequence whereas substitutions are indicated by the single letter code for the changed amino acid. Gaps are shown as
dashes.
f Determined by using the algorithm available on http://www.geno2pheno.org/cgi-bin/geno2pheno.pl.












Fig. 1. Determination of viral co-receptor usage of chimeric viruses from 11 seminal
plasma samples not consecutively numbered 594 to 805 and successfully ampliﬁed by
nested PCR performed in the V1–V3 region. The experiments were performed after
16 days of ampliﬁcation by co-culture with PBMCs as measured by induction of β-Gal
activity 48 h after virus–cell incubation for parallel cultures of U373-X4 (open bars) and
U373-R5 (grey bars) reporter cells. ‘Vector only’ and ‘Medium only’ refer to control
conditions in which cells were incubated with supernatants from 293T cells transfected
with the pNL 43 ΔV vector only and with cell culture medium only, respectively. Optical
densities greater than twice the background values were considered positive (dotted
lines). Results shown are the mean of three replicates per measure.
375P. Lawrence et al. / Virology 386 (2009) 373–379In order to overcome the difﬁculties inherent in the isolation of
cell-free or cell-associated seminal strains, we adapted a technique
originally developed to test the tropism of viral strains using the V1–
V3 deleted vector pNL 43 (Trouplin et al., 2001) for the construction of
chimeric viruses expressing the V1–V3 region of envelope protein
fromwild-type seminal HIV-1 strains. Using this method, we obtained
four replicating seminal-derived strains characterised for their CXCR4
tropism and able to interact as cell-free particles with a reporter cell
line, as demonstrated by confocal microscopy.
Results
Ampliﬁcation of V1–V3 from seminal and blood strains
Fragments of 940 bp containing the envelope region spanning V1–
V3 of HIV-1 were successfully ampliﬁed by nested-PCR from 11
seminal plasma samples from HIV-infected subjects and, as controls,
from the laboratory strains HIV-1LAI and HIV-1BAL. The clinical data of
these 11 subjects are given in Table 1. For 6 of the 11 positive seminal
samples, the V1–V3 region was also ampliﬁed by PCR from
corresponding blood samples available at the same time. The V3
region was sequenced in order to compare blood and plasma strains.
Differences were observed for 4 of the samples tested, with between 1
and 4 amino acid changes in the V3 loop.
Construction and growth characteristics of chimeric viruses
After co-transfection of bulk V1–V3 fragments together with the
43 ΔV deleted vector in 293T cells, all supernatants tested positive by
p24 assay (mean level 200 ng/ml, ranging from 156 to 224, data not
shown). As expected, the chimeric LAI and BAL controls gave positive
signals on CXCR4+ and CCR5+ cells, respectively (data not shown).
Testing of the above supernatants by the tropism recombinant test
(TRT) described by Trouplin et al. (2001) gave a positive signal on
CXCR4+ cells for two supernatants (samples 609 and 728). None of
the supernatants was found positive with the CCR5+ cells.
In order to assess the cultivability of the chimeric viruses
potentially generated by transfection experiments, all of the 11
supernatants and chimeric LAI and BAL controls were cultured with
PHA/IL-2 activated PBMC for 16 days and quantiﬁed daily by p24
assay. Four strains (594, 705, 728 and 804) were found positive (data
not shown). These strains also tested positive on CXCR4+ cells by the
TRT, indicating the presence of PBMC-ampliﬁed X4 strains (Fig. 1).
Interestingly, the lack of positivity for sample 609 after culture with
PBMC (Fig. 1) despite a positive signal with the X4-TRT at day 0 and
the detection of proviral DNA (data not shown) suggests that this
chimeric virus was able to exhibit only one cycle of replication.
To investigate further the seminal samples from six patients found
negative by the TRT (611, 654, 662, 802, 803 and 805), mixes of
corresponding initial V1–V3 PCR products were each sub-cloned.
Between 15 and 20 sub-clones were used to produce chimeric viruses.
Testing of these supernatants by the TRT gave a positive signal on
CCR5+ cells for two samples (611 — 4 distinct proﬁles and 654 — 2
proﬁles). Some of these clones were shown to present 1 to 3 amino
acid differences when compared to the predominant proﬁle; inter-
estingly, one clone from sample 654 exhibited 12 amino acid changes.
In order to assess the replicative capacity of these recombinant
viruses, supernatants were cultured with PHA/IL-2 stimulated PBMCs
and cultures were tested for p24 production daily for 16 days. No p24
production was observed for these viruses, despite positive proviral
DNA detection, suggesting the presence of infectious, one-cycle
particles (data not shown).
The four replicative chimeric strains characterised above and the
chimeric controls were tested for their infectivity on U373-X4 and -R5
reporter cells. Limiting serial dilutions of either PBMC culture
supernatants or infected PBMC stocks were used to determine theirinfectivity. Viral stock concentrations were as follows for cell-free
virus (as expressed in ng/ml of p24) and for PBMC infected with
chimeric viruses (as expressed in number of proviral DNA copies for
5×105 total cells), respectively: 1.15 and 5.9×104 for strain 594, 1.10
and 2.7×104 for strain 705, 1.52 and 1.6×104 for strain 728, and 1.34
and 3,3×104 for strain 804.
Tropism characterization
To assess the absence of divergence during transfection and
ampliﬁcation steps, the sequences of the V3 loop of the replicative
chimeric viruses (4 seminal strains and controls) were compared with
those from the corresponding initial V1–V3 RT-PCR products. No
differences were encountered for any strain (data not shown). In order
to compare the observed phenotropism of the chimeric strains with
their genotype proﬁle, sequencing of the V1–V3 region of the env gene
was performed on PCR products ampliﬁed from infected PBMC (Table 1)
and the genotypic tropism was predicted using a deﬁned algorithm
(http://www.geno2pheno.org/cgi-bin/geno2pheno.pl). Globally, a
consensus was observed between this analysis and the TRT. However,
two seminal clones were found to exhibit discordant proﬁles: R5 from
V3 sequence-based prediction and X4 from the TRT for strain 594 and
the opposite pattern for sub-clone 654–5.
As shown in panels A and E of Fig. 2, the presence of viral p24
antigen was detectable at the surface of U373-X4 cells incubated with
chimeric X4-tropic strains LAI or seminal strain 728 by confocal
Fig. 2. Visualization of viral infection of U373 cells by confocal microscopy. The presence of p24 antigen (shown in red) was detectable at the surface of the cells after 1 h of incubation
of LAI ΔV with the U373-X4 cell line (panel A), BAL ΔV with the U373-R5 cell line (panel C) or the chimeric strain 728 with the U373-X4 cell line (panel E). No signal was seen if
viruses were incubated with the U373 cell line expressing the non-appropriate co-receptor, as LAI ΔVwith the U373-R5 cell line (panel B). The p24 signal was lost if virus-containing
supernatants (BAL ΔV in panel D and strain 728 in panel F) were pre-incubated for 30 min with suramin.
376 P. Lawrence et al. / Virology 386 (2009) 373–379microscopy. Similar images were obtained for R5-tropic strains
incubated with U373-R5 cells (Fig. 2C). This signal was lost if the
virus-containing supernatants were pre-incubated with suramin
(Figs. 2D and F), suggesting the presence of a functional V3 loop
region for the recombinant viruses and its involvement in virus–cell
interactions. A lack of p24 signal was also observed if U373 cells
expressing an inappropriate co-receptor were incubated with these
same viruses (Fig. 2B), indicating that these interactions were co-
receptor-speciﬁc.
Discussion
Diverse tissues of the genital tract can serve as sites of HIV-1
replication and these sites are likely to differ from the peripheral
environment in terms of target cell characteristics and immunological
pressures (Coombs et al., 2001; Kiessling, 1992; Paranjpe et al., 2002).
These differences have been shown further by studies dealingwith thelow correlation in some patients between viral loads in semen and
blood, both in terms of RNA and provirus (Ball et al., 1999; Bourlet et
al., 2001; Tachet et al., 1999). Virus replicating within the genital tract
can therefore develop distinct genetic characteristics (Byrn et al.,
1997; Delwart et al., 1998; Ghosn et al., 2004b; Ping et al., 2000 and
this study). Moreover, genotypic differences in the C2/V5 region of
gp120 of viruses from seminal cells and plasma from the same patient
(Paranjpe et al., 2002) suggest the existence of a sub-compartmenta-
lisation of HIV within mucosal secretions of the genital tract; the
round cells and seminal plasma can be considered as two separate
compartments, each containing distinct viral variants. In addition,
efﬁciencies of drug penetration may also differ and although
antiretroviral therapy appears to inﬂuence HIV levels in rectal and
seminal ﬂuids as well as in blood, higher RNA levels have been
observed in mucosal secretions, highlighting the importance of
anatomic viral compartmentalisation in the selection of mucosal-
speciﬁc resistance patterns (Ghosn et al., 2004a, b).
377P. Lawrence et al. / Virology 386 (2009) 373–379Given that there is evidenceof genetic differences betweenbloodand
semen-derived HIV-1 strains, it would seem pertinent to use viruses of
seminal origin in in vitro or ex vivo studies dealing with interactions
between vaginal mucosa and virus. Unfortunately, the ampliﬁcation of
HIV-1 strains from seminal samples by culture with PBMCs is fastidious
and has low sensitivity, ranging from 9% to 55% (Coombs et al., 1998;
Vernazza et al., 1997). In addition, extensive culturing of HIV-1 particles
with PBMCs could lead to the selection of restricted strains thatmay also
lead to the misrepresentation of the initial virus population. This is in
part due to culturing PBMCs in the presence of interleukin-2 and
phytohemagglutinin that may favour the expression of CXCR4 with
respect to CCR5 (Bleul et al., 1997; Boyd et al., 1993).
In order to overcome the difﬁculties inherent in the isolation of
seminal strains, we present here the adaptation of a technique originally
developed to test the tropism of viral strains to construct replicative
chimeric viruses expressing wild-type seminal HIV-1 envelope protein
(Trouplin et al., 2001). From the eleven samples tested, the use of bulk
PCRproducts allowed the obtention of four replicating strains (594, 705,
728, and 804). All of these four viruses were X4-tropic by the TRT,
raising the question of a preferential selection of X4 variants in this
protocol combining transfection with pNL43 and PBMC culture.
However, sequencing results show that the V1–V3 regions of these
X4-tropic chimeric strains were those that were present in the original
bulk PCR products obtained from the semen of the ﬁve patients. In
addition, these four samples were obtained from patients exhibiting a
symptomatic phase of HIV infection (Table 1), making the detection of
X4 strains plausible in this context. Even if it was necessary to cultivate
the chimeric viruses with PBMC in order to increase the relatively low-
level virus production observed with this transfection system, no
genetic divergence was shown to be introduced by a single cycle of
PBMC ampliﬁcation, as assessed by sequencing of the V1–V3 region
before and after culture.
Of the remaining six samples, two were included successfully in
further sub-cloning experiments; one sample (611) gave four distinct
R5-like V3 proﬁles and the other (654) two different proﬁles (one X4,
one R5). These viruses were all revealed to be R5-tropic by the TRT but
were capable of only one cycle of PBMC infection despite the absence of
apparent anomalies (stop codons, frame-shifting deletions or inser-
tions) in the proviral V1–V3 regions ampliﬁed from infected PBMCs. For
these strains, amisalignment during the recombination of PCR products
and deleted vector cannot be excluded. However, these viruses still
represent useful strains for studying the initial steps of viral infection.
Interestingly, a CRF02_AG strain was found able to produce chimeric
viruses suggesting that this cloning strategy is not clade-dependant.
The chimeric viruses that were unable to infect target cells (662,
802, 803, and 805), even after sub-cloning, may represent defective
circulating viruses present in the initial seminal samples that were
selected by PCR and cloning steps. It has been shown that V3
mutations can lead to a major loss of entry ﬁtness or even to lethality
or that V1/V2 mutations in the absence of V3 mutations can alter co-
receptor usage (Pastore et al., 2006). Also, it cannot be excluded that
some primary sequences may not be functional in the context of the
NL43 vector used here.
As already mentioned, some discrepancies were observed in this
study between the actual viral phenotropism determined by the TRT
and the genotropism predicted from the amino acid composition of
the corresponding V3 loop (for a recent overview see (Sander et al.,
2007; Xu et al., 2007)), conﬁrming that other regions of gp160 are
implicated in co-receptor usage, as recently described (Huang et al.,
2008; Taylor et al., 2008). Given that mathematical-based prediction
algorithms are not 100% reliable, greater weight must obviously be
given to actual phenotypic results for the characterisation of these
chimeric strains. At a therapeutic level, this observation may have
important consequences for determining which patients may beneﬁt
from the use of entry inhibitors able to interact with a single class of
co-receptor (Van Baelen et al., 2007).In the absence of easily available cell-free or cell-associated
primary isolates of seminal origin, most studies have turned to pure
laboratory or blood-derived strains that may beweakly representative
of the actual infectious, circulating strains responsible for the majority
of HIV infections worldwide. The biological determinants that
inﬂuence the heterosexual transmission of different viral strains
from the seminal tract are still poorly understood. To our knowledge,
previous studies dealing with interactions between mucosa and virus
have never used primary isolates from seminal origin but laboratory
or blood-derived isolates (Berlier et al., 2005; Dezzutti et al., 2001;
Fotopoulos et al., 2002; Gupta et al., 2002; Hocini and Bomsel, 1999;
Meng et al., 2002; Van Herrewege et al., 2007; Wu et al., 2003).
Therefore, it would appear crucial to use seminal strains for the study
of heterosexual transmission in in vitro models, at least to conﬁrm
results obtained with commonly used laboratory strains. As it would
seem that the transfer of virus from infected cells present in the semen
is the most efﬁcient form of viral transmission and therefore route of
primary infection (Tan and Phillips, 1996), it is also necessary to test
any in vitro model system using infected cells. These replicative
chimeric seminal viruses represent useful tools for the study of the
heterosexual transmission of HIV-1 using models of genital barriers,
testing of microbicide activity and for mucosal immunity.
Materials and methods
Seminal samples and HIV-1 strains
Seminal samples were obtained from 11 HIV-1 infected males
followed at the Department of Infectious Diseases of the University
Hospital of Saint-Etienne and tested positive by RT-PCR. As shown in
Table 1, these subjects presented a blood viral load of more than 1000
copies/ml. All of them gave a written, informed consent. The cell-free
fraction of seminal plasma was separated from whole semen by
centrifugation for 30 min at 800 ×g and stored at −80 °C until use.
Two laboratory strains, HIV-1LAI (X4-lymphocytotropic) and HIV-1BAL
(R5-monocytotropic) were used as controls.
Cell culture
The 293-T cell line was cultured in Eagle's minimum essential
medium supplemented with 10% foetal calf serum (FCS) and
antibiotics (Sigma Aldrich, Saint-Quentin Fallavier, France).
U373MG-CD4 cells, a kind gift from M. Alizon (INSERM U332, Paris,
France), are transfected with an expression vector for one of the
chemokine receptors CCR5 or CXCR4 and contain an HIV-1 long
terminal repeat (LTR)-LacZ cassette allowing the detection of infection
via the Tat-induced expression of β-galactosidase (β-Gal). Referred to
here as U373-R5 and U373-X4 cells, respectively, they were cultured
in Dulbecco modiﬁed Eagle medium supplemented with 10% FCS and
antibiotics in the presence of 10 μg/ml of puromycine and 100 μg/ml
of hygromycin-B (Labrosse et al., 1998). Human PBMCs, obtained after
Ficoll separation from leukocyte concentrates from healthy donors,
were routinely cultured in RPMI 1640 medium supplemented with
10% FCS and antibiotics; their activation was carried out 2 days before
virus infection by the addition of 5 μg/ml of PHA-P (Sigma-Aldrich)
and 20 μg/ml of IL-2 (AbCys, Paris, France).
Ampliﬁcation of the V1–V3 region of the HIV-1 envelope
Total RNA was puriﬁed from seminal plasma samples, blood
plasma or from culture supernatants using the QIAamp Viral RNAmini
kit (Qiagen, Courtaboeuf, France). An initial reverse transcription-PCR
was carried out, followed by a nested PCR, according to the protocol of
Trouplin et al. (2001). Both PCRs were performed using the Expand
High Fidelity PCR system (Roche Diagnostics, Meylan, France). By this
approach, 940-bp-long products that span the V1–V3 region deleted
378 P. Lawrence et al. / Virology 386 (2009) 373–379from the 43 ΔV vector were obtained, with approximately 150-bp
extensions on each side to allow homologous recombination during
transfection. PCR products were veriﬁed for their size by agarose gel
electrophoresis and were puriﬁed by the Qiagen PCR puriﬁcation kit
prior to use in transfection experiments.
Production of recombinant viruses by transfection
Recombinant viruses exhibiting the V1–V3 region of the HIV-1 env
gene from seminal strains were produced by co-transfection in 293T
cells of PCR products with the HIV-1 genomic construct V1–V3 deleted
vector (43 ΔV), as described previously (Trouplin et al., 2001). The 43
ΔV vector was a kind gift from F. Mammano (Pasteur Institute, Paris,
France). As control, cells were transfected with the 43 ΔV vector in the
absence of PCR product. Five ml of virus-containing supernatant was
collected 48–72 h after transfection, clariﬁed by centrifugation and
tested by p24 ELISA assay.
Quantiﬁcation of p24 antigen by ELISA
The following monoclonal antibodies directed against the p24
protein of HIV-1 were used in a classical sandwich ELISA on 96-well
microplates; D7320 and BC 1071 (Aalto Bio Reagents, Dublin, Ireland).
Serial dilutions of a recombinant p24 protein (5109, Aalto Bio
Reagents) were used to establish a concentration gradient for
quantitative analysis. An ELISA Ampliﬁcation System® (Invitrogen,
Cergy-Pontoise, France) was used to enhance assay performance
following manufacturer's instructions. The sensitivity of this assay
was estimated to be approximately 40 pg/ml of p24 protein.
Chimeric virus ampliﬁcation and titration
Virus-containing supernatant from co-transfected 293-T cells was
used to infect PHA/IL-2 stimulated cultures of PBMCs. To assess viral
production, a sample of culture supernatant was taken every day for
16 days, cleared by centrifugation and quantiﬁed by p24 ELISA. PBMC
supernatants presenting the highest p24 load (expressed in ng/ml)
were further controlled for RNAviral load (expressed in copies/ml) by
using a real-time PCR assay (HIV RealTime, m2000rt, Abbott
Molecular, Rungis, France). The amount of proviral DNA in the
corresponding PBMC fractions collected after 48 h of infection was
determined as described by O'Doherty et al. (2002).
Determination of viral phenotropism by the TRT
The determination of the replicative capacity of the chimeric
strains was also assessed using the TRT as detailed in Trouplin et al.
(2001). Co-receptor usage was determined by measurement of CPRG
in the two target cell lines by comparison with cells exposed to
supernatant from cells transfected with the 43 ΔV vector in the
absence of PCR products (background). Optical densities greater than
twice the background value were considered positive. Results were
recorded from at least three independent experiments.
Sequencing of the V1–V3 region
Sequencing of the V1–V3 region of the env gene was performed on
the initial V1–V3 RT-PCR products and, as a control of viral sequence
divergence, on V1–V3 PCR products ampliﬁed from infected PBMCs.
Following puriﬁcation of PCR products (QIAquick gel extraction kit,
Qiagen), a 900 bp-long fragment of the V1–V3 region was sequenced
using the primers E20 and E115 (Trouplin et al., 2001) and the DTCS
kit (Beckman-Coulter, Villepinte, France) on a Beckman 2000
automated sequencer following manufacturer's recommendations.
The sequences were analysed by performing multiple sequence
alignment using CINEMA 5 software (version 0.2.1. BETA, http://aig.cs.man.ac.uk/utopia) with minor adjustments. Vector clone pNL43
and HIV-1BAL were used as references. All V1–V3 sequences from
seminal strains reported here have been submitted to the GenBank
database with the following accession numbers: EU977327 to
EU977341, consecutively.
Subcloning of the V1–V3 region
RT-PCR-ampliﬁed material from six seminal plasma samples was
sub-cloned using the Qiagen PCR Cloning kit according to the
manufacturer's instructions. To increase the likelihood of amplifying
and detecting different viral variants present in seminal plasma
samples, a mixture of at least 6 nested PCR products was used for
cloning. Veriﬁcation of the clones was carried out by PCR using the
primers E20 and E115 on single colonies grown overnight in Luria
Bertani medium following puriﬁcation with the QIAprep Miniprep kit
(Qiagen) according to manufacturer's instructions.
Confocal microscopy
Cells were grown to 70% conﬂuence on glass coverslips in 24-well
plates before incubation at 37 °C with viral strains for the indicated
time. Cells were ﬁxed in 3.7% paraformaldehyde-PBS for 12 h and then
incubated for 20 min in 50 mM NH4Cl to quench free aldehydes. After
an incubation of 20 min in 0.4% Triton X-100-PBS, the cells were
incubated for 1 h with relevant antibodies (HIV-1 p24 Monoclonal
Antibody 183-H12-5C, AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH; coupledwith Alexa Fluor 555, Invitrogen,
and for nuclear staining 7-AAD, Becton Dickinson, Le Pont-De-Claix,
France) in PBS with 10% FCS. Following washing steps, coverslips were
mounted using Fluoprep mounting medium (Biomerieux, Marcy-
l'Etoile, France) and left overnight at 4 °C. Cells were analysed with a
LEICA TCS-SP2 confocal scanning laser microscope used with pulsed
near infrared excitation (multiphoton mode) and software. The
excitation laser was a COHERENT MIRA 900 with a 76 MHz repetition
rate and a 790 nm wavelength. Image stacks were further analysed
using ImageJ software (Abramoff et al., 2004). In certain experiments,
virus containing supernatants were pre-incubated for 30 min with
5mg/ml of suramin (Sigma-Aldrich), a polyanionic compound known
to interfere with the V3 loop of gp120 (Yahi et al., 1994).
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